Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis: The IXORA-PEDS Randomized Clinical Trial

por Paller, Amy S., Seyger, Marieke M. B., Magariños, Gabriel A., Pinter, Andreas, Cather, Jennifer C., Rodriguez-Capriles, Claudia, Zhu, Danting, Somani, Najwa, Garrelts, Alyssa, Papp, Kim A.
Publicado 2022